ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Advisors tell NCI to rethink contracts for clinical trials cooperative group tissue banks

November 21, 2003

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Proposed Deal Could Resolve Key Disputes At NSABP, Pitt

January 13, 1995

Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening

April 2, 1999

Virus Working Group Suggests 14 Projects As Suitable For New Contract Proposals

March 1, 1974

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003